THOMAS BRAXTON KING
CIK 1279309 · Executive Chairman · last filed 2025-09-08
THOMAS BRAXTON KING is an Executive Chairman who has filed 65 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for ACHV, was dated Sep 8, 2025. Across all open-market trades the lifetime net is −$577.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.74M
5
65
-$577.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACHV | Executive Chairman | 315,142 | $5.52 | $1.74M | -$387.4K | 6 | 2025-09-08 |
| TFF Pharmaceuticals, Inc. (TFFP) Delisted | Director | 1,583 | $0.07 | $103 | $0 | 3 | 2024-07-08 |
| Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Director | — | $1.10 | — | $0 | 4 | 2023-06-08 |
| VIVUS INC (VVUS) Delisted | Interim Chief Executive Office | — | — | — | $0 | 5 | 2020-02-24 |
| Alexza Pharmaceuticals Inc. (ALXA) Delisted | President & CEO | 77,223 | — | — | -$190.5K | 46 | 2015-11-03 |
Recent Filings
65 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-08 | ACHV | Mixed | +315,142 | -$387.4K | EDGAR |
| 2025-06-10 | ACHV | Grant (A) | — | $0 | EDGAR |
| 2025-01-14 | ACHV | Grant (A) | — | $0 | EDGAR |
| 2024-07-08 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | +1,583 | $0 | EDGAR |
| 2024-04-22 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-24 | ACHV | Grant (A) | — | $0 | EDGAR |
| 2023-12-15 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | ACHV | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-03-30 | ACHV | Grant (A) | — | $0 | EDGAR |